Suven Pharmaceuticals consolidated net profit declines 49.61% in the June 2024 quarter

09 Aug 2024

Suven Pharmaceuticals consolidated net profit declines 49.61% in the June 2024 quarter

Net profit of Suven Pharmaceuticals declined 49.61% to Rs 60.77 crore in the quarter ended June 2024 as against Rs 120.59 crore during the previous quarter ended June 2023. Sales declined 33.62% to Rs 230.69 crore in the quarter ended June 2024 as against Rs 347.55 crore during the previous quarter ended June 2023.

ParticularsQuarter Ended
Jun. 2024Jun. 2023% Var.
Sales230.69347.55 -34
OPM %34.6548.04 -
PBDT96.49176.48 -45
PBT83.09163.94 -49
NP60.77120.59 -50

Top Blogs

blog-article-image-one

Share Market

What is the Bombay Stock Exchange?

10 mins read . Dec 9, 2024

blog-article-image-one

Share Market

Stocks Under 5 Rupees in India

13 mins read . Dec 9, 2024

blog-article-image-one

Share Market

Stocks Under 1000 Rupees in India

14 mins read . Dec 6, 2024

Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions